Helpdesk

Sales contact

Home > Resources > Emerging Biopharma & Biotech (EBP) – 5 key success factors for your clinical trials

Emerging Biopharma & Biotech (EBP) – 5 key success factors for your clinical trials

26 July 2023

With so much at stake, consider partnering with an eCOA and DCT expert!

Kayentis offers a unified platform featuring trustworthy services to ensure the success of electronic Clinical Outcome Assessment (eCOA) and decentralized clinical trials (DCT):

18+ years’ eCOA experience navigating diverse clinical trial challenges

A unified platform for decentralized clinical trials enhancing patient and site experience

Trusted partnership ensuring top-quality service delivery

Clinical and scientific experts empowering and supporting your teams

Therapeutic expertise addressing the unique needs of specific populations

Subscribe to our newsletter

If Patients Want A Better Quality Of Life, Why Isn’t...

Strategies to overcome clinical trials complexities

Kayentis 2024 Gender Equality Index

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to...

The unquestionable value of electronic Clinical Outcome Assessments (eCOA) in...

Breaking barriers in pediatric clinical trials: perspectives from two expert...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events